Upload
don-duval
View
591
Download
1
Tags:
Embed Size (px)
DESCRIPTION
This keynote presentation was given at the global Bio-Connect Conference at the World Trade Centre Morelos in Cuernavaca, Mexico on November 29, 2011. The presentation highlighted the MaRS Life Sciences / Healthcare portfolio, the EXCITE pre-market assessment initiative in the Ontario healthcare system, and the role that MaRS Innovation plays to expedite the commercial outcomes from the intellectual property out of Canada's leading research and academic institutions.
Citation preview
Building Canada’s next generation of growth companies
Driving Commercial Outcomes from Innovation and Technology - The MaRS Discovery District Case Study November 29th 2011
There are three objectives that I hope to achieve in today’s presentation:
1. Provide an overview of MaRS, our mandate, and the programs and services we offer
2. Discuss the MaRS Life Sciences and Healthcare Practice, MaRS Innovation, and the MaRS EXCITE program
3. Provide an opportunity to address any questions you may have
2
MaRS is a non-profit innovation centre connecting science, technology and social entrepreneurs with business skills, networks and capital
MaRS helps to create successful global businesses from Canada’s science and technology
Mission
Who we Serve
Early stage science and technology ventures and innovative social purpose businesses
Measure of Success Job and wealth creation for the economy
3
5
Discovery Details in Notes Part of Slide
pg 8
Phase I"Phase II"
Discovery District Financial District Creative & Arts District
Gardiner Museum of Ceramic Art Royal Ontario Museum
Women’s College
The MaRS Centre UHN Toronto General Hospital for Sick children
Entertainment District
Four Seasons Centre
University of Toronto
UHN Princess Margaret Mount Sinai
Art Gallery of Ontario
Royal Conservatory of Music
TIFF & OCAD
Financial District
Toronto Rehab Ryerson University
10
pg 11
Building Next Generation Startups
Improving Commercialization
Output from Academe
12
MaRS Innovation
13
¨ A professionally managed, business accelerator platform as a single point of entry for industry partners and investors
¨ Funding of MaRS Innovation and distribution of revenues are
based upon an agreed upon formula amongst all member institutions
¨ Currently trending with approximately 300 disclosures per year, approximately 70% of which are life sciences, medical device, or healthcare IT sectors
¨ Cash contributions from member institutions are based pro-rata on the annual research budget for each institution
14
Educationand Insight"
Entrepreneurship Education
Market Research"Thought Leadership"
Access
to Capital""
Angels"Venture Capital"
Corporations"Government Programs"
Foundations""
Business Advice and Mentorship"
"Advisors"
Volunteers""
Networks, Talent, Customers and Partners"
Programs for High Growth Ventures, Policy Initiatives, and Special Projects "
15
ICE Cleantech Life Sciences
and Healthcare
| |
Due Diligence Financing
Human Resources and Talent Management
Intellectual Property
Market/Competitive Intelligence
Marketing & Sales
Corporate Governance
Financial Management, Accounting, Tax
Legal Product Development and Marketing
Operations and Process Customer Relationship Management
Strategic Partnerships
Strategy and Business Planning
Partners Volunteers MaRS Advisors
| Social
| |
16
Pg 17
¨ Approximately 125 active ventures in the MaRS portfolio, working with an array of mentors and advisors
¨ Provision of market intelligence, educational resources, and continuing to build strong connections to capital and market opportunities
¨ Highly integrated and supportive of MaRS Innovation clients; pipeline of high quality deal flow
Logoʼs from ArcticDX, Profound Medical, "
Single Commercialization Storefront for Toronto’s Academic Institutions
Business Accelerator for Ontario’s Emerging
Companies
Entrepreneurs from across Ontario and
the country"St
art-u
ps"
Member Institutions"
Lice
nsin
g &
Indu
stry
C
o-de
velo
pmen
t "
18
Memory at Work
NEW TECHNOLOGIES"
END USERS"
Currently there is limited crosstalk during the development process can mean greatly protracted timelines before new technologies are adopted or even a reluctance to adopt new technologies
Pg 19 19
Unrealized improvements
Demand "
disconnect""
A novel approach that matches health technology innovation with patient needs and health system priorities"
"
NOW"
New Canadian "
Medical Technologies"
New Canadian and International"
Medical Technologies"
Pre-market feedback loop"
More relevant technologies"""
20
Memory at Work
Current Evaluation Process"
Technology Development"
Market Approval"
Sub-optimal Adoption by Health Systems"
Pre-Market"Evaluation"
(Risk-Based)"
Post-Market"Evaluation"
(Evidence-Based)"
Incorporates technology improvements"
Reflects health care priorities"
"
EXCITE Pre-Market Evaluation Process"
Technology Development with Evaluation Improvements"
Market Approval"
Optimal Adoption by Health Systems"
Pre-Market"Evaluation"
(Evidence-Based)"
21
Impact"
Business Services"
Ecosystem Development"
IP Development |"
MaRS Advisory |"
Market Intelligence |"
Entrepreneurship Education"
Capital & Investment"
Strategic Partnerships | Stakeholder Support"
Community Programs |" Awards & Recognition"
Talent & Knowledge Management "
Real Estate Services "
MaRS Centre Development "
IT/AV Services"
Office & Laboratory Facilities | MaRS Incubator "
MaRS Collaboration Centre l "
Public Policy "
22
Don Duval"Email: [email protected]"Twitter: don_duval"Speakerfile: don.duval"